|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash, including amounts held by variable interest entities (VIEs) of $7,259 and $128 | ||||||||||||||||||||
| Consumer receivables, net, including amounts held by VIEs of $101,981 and $92,796 | ||||||||||||||||||||
| Consumer receivables | ||||||||||||||||||||
| Allowance for credit losses on consumer receivables | ||||||||||||||||||||
| Consumer receivables, net, including amounts held by VIEs of $83,608 and $131,283 | ||||||||||||||||||||
| Consumer receivables held for sale | ||||||||||||||||||||
| Enterprise receivables, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Secured loans | ||||||||||||||||||||
| Secured loans, net | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Other debt, including amounts held by VIEs of $143,000 and $0 | ||||||||||||||||||||
| Other debt, net, including amounts held by VIEs of $51,131 and $125,419 | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable convertible preferred stock (Series A), $0.0001 par value; 45,000,000 shares authorized as of September 30, 2023 and December 31, 2022, 0 and 25,655,579 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Stockholders' equity : | ||||||||||||||||||||
| Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ||||||||||||||||||||
| Class A Common Stock, $0.0001 par value; 66,666,666 shares authorized as of December 31, 2024 and December 31, 2023, 11,362,652 and 11,300,081 issued and outstanding, respectively, as of December 31, 2024 and 10,444,627 and 10,412,294 issued and outstanding, respectively, as of December 31, 2023 | ||||||||||||||||||||
| Total class A Common Stock, $0.0001 par value; 66,666,666 shares authorized as of December 31, 2024 and December 31, 2023, 11,362,652 and 11,300,081 issued and outstanding, respectively, as of December 31, 2024 and 10,444,627 and 10,412,294 issued and outstanding, respectively, as of December 31, 2023 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock at cost, 62,571 and 32,333 shares as of December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||||||
Loading...